Charles River Laboratories | CRL

Charles River Laboratories traded at $226.47 this Thursday August 11th, decreasing $0.05 or 0.02 percent since the previous trading session. Looking back, over the last four weeks, Charles River Laboratories lost 4.11 percent. Over the last 12 months, its price fell by 44.46 percent. Looking ahead, we forecast Charles River Laboratories to be priced at 217.19 by the end of this quarter and at 199.64 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Agilent 131.95 -0.63 -0.48% -16.57%
AmerisourceBergen 148.22 2.64 1.81% 23.48%
Align Technology 287.38 -0.43 -0.15% -59.19%
Elevance Health Inc 477.11 -4.22 -0.88% 29.78%
Bio-Rad Laboratories 549.12 0.63 0.11% -28.36%
Bruker 62.00 -0.05 -0.08% -25.01%
Cardinal Health 66.00 3.25 5.18% 26.73%
Cigna 286.00 -1.07 -0.37% 35.80%
Charles River Laboratories 226.47 -0.05 -0.02% -44.46%
Catalent 109.94 -2.90 -2.57% -8.60%
CVS Health 104.25 0.20 0.19% 22.45%
Quest Diagnostics 140.57 -0.41 -0.29% -5.07%
Danaher 291.18 0.04 0.01% -7.64%
Galapagos 52.98 0.26 0.49% 6.19%
Hologic 72.07 -0.17 -0.24% -6.17%
Humana 484.07 -1.93 -0.40% 19.31%
Illumina 227.44 0.14 0.06% -55.46%
Incyte Corp 73.76 -0.37 -0.50% 1.18%
IQVIA Holdings Inc 242.00 2.31 0.96% -1.73%
Laboratory Of America 258.74 -0.37 -0.14% -13.90%
Lonza Group 584.00 14.20 2.49% -19.11%
McKesson 358.76 -0.85 -0.24% 81.20%
Allscripts Healthcare Solutions 17.11 -0.49 -2.78% 0.12%
Merck 187.10 -0.70 -0.37% -2.35%
Mettler Toledo International 1,346.79 0.01 0.001% -11.29%
Novartis 81.04 -1.47 -1.78% -5.48%
Pfizer 48.29 -1.66 -3.32% 2.22%
PerkinElmer 160.96 2.70 1.71% -11.70%
Thermo Fisher Scientific 592.54 0.19 0.03% 8.79%
UnitedHealth 532.86 -4.86 -0.90% 30.07%
United Therapeutics 220.41 -1.08 -0.49% 8.55%
Waters 331.62 0.83 0.25% -17.37%
Walgreens Boots Alliance 40.07 0.17 0.43% -18.76%
West Pharmaceutical Services 337.75 -1.09 -0.32% -21.40%
Intrexon 2.32 -0.10 -4.13% -62.09%
Dentsply International 37.17 0.13 0.35% -37.00%

Indexes Price Day Year
US400 2576 15.21 0.59% -5.91%

Charles River Laboratories
Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company provides products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions in research and drug development. The Company operates through two segments: Discovery and Safety Assessment (DSA) and Manufacturing Solutions (Manufacturing). The DSA segment includes services required to take a drug through the early development process including discovery services, which are non-regulated services to assist clients with the identification, screening, and selection of a lead compound for drug development, and regulated and non-regulated (Good Laboratory Practice (GLP) and non-GLP) safety assessment services. The Manufacturing segment includes Microbial Solutions, Biologics Solutions, and Avian Vaccine Services.